Similarly, Kingwell et al. (15) identified a 4.4% cancer incidence in patients treated with interferon beta, predominantly involving breast, lung, and prostate cancers (15) – but the latter two were not reported in our investigation. The gene discussed is IFNB1; the disease is prostate cancer.